ArticleMycotoxin research2026
Effects of Enniatin B1 on differentiated Caco-2 human intestinal cells in vitro.
Article in Mycotoxin research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Enniatins (ENNs), naturally occurring contaminants in food and feed, are emerging mycotoxins currently not regulated. The purpose of this study was to evaluate the possible effects of ENN B1 following oral exposure using a human-based intestinal epithelial barrier model. Caco-2 intestinal cells, cultivated on semipermeable filters to obtain the formation of an apical compartment (intestinal lumen) and a basolateral compartment (vascular/lymphatic), were exposed for 24–48 h to apical concentrations of ENN B1 ranging from 0.5 to 6 µM, simulating intestinal mycotoxin exposure. The effects on Trans Epithelial Electrical Resistance (TEER) and interleukin 8 (IL-8) release were evaluated, and a morphological characterization was performed using confocal microscopy and immunofluorescence technique to assess the localization of zona occludens protein 1 and occludin for tight junctions (TJ), and E-cadherin and beta-catenin for adherens junctions (AJ). TEER data showed the absence of adverse effects, even following exposure to higher doses (6 µM) of ENN B1. However, exposure to the mycotoxin for 24 and 48 h caused significant increases in apical secretion of IL-8 as compared to untreated control cells. Moreover, the results obtained from confocal microscopy suggest that exposure to ENN B1, even if it does not alter epithelial permeability, can affect intercellular junctional organization. Further studies are needed to explore these aspects and evaluate the in vitro bioavailability and kinetics of ENN B1 using human-based barrier models.
Indexed as
Identifiers
41832295What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.